| Record status | This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. |
|---|
| Bibliographic details | National Institute for Health and Clinical Excellence. Rituximab for the treatment of follicular lymphoma. London: National Institute for Health and Clinical Excellence (NICE) 2006: 20
|
|---|
| Authors' objectives | The aim of this review is to provide guidance on the use of rituximab for the treatment of follicular lymphoma.
|
|---|
| Authors' conclusions | Guidance
Rituximab within its licensed indication (that is, in combination with cyclophosphamide, vincristine and prednisolone) is recommended as an option for the treatment of symptomatic stage III and IV follicular lymphoma in previously untreated patients.
|
|---|
| URL for original research | http://www.nice.org.uk/page.aspx?o=TA110 |
|---|
| Subject index terms status | Subject indexing assigned by CRD |
|---|
| Subject index terms | Antibodies, Monoclonal /therapeutic use; Antineoplastic Agents /therapeutic use; Cyclophosphamide /therapeutic use; Lymphoma, Follicular /drug therapy; Prednisolone /therapeutic use; Vincristine /therapeutic use |
|---|
| Language | English |
|---|
| Address for correspondence | MidCity Place, 71 High Holborn, London WC1V 6NA, UK Tel: +44 020 7067 5800; Fax: +44 020 7067 5801
 nice@nice.nhs.uk |
|---|
| Accession number | 32006000958 |
|---|
| Database entry date | 9 October 2006 |
|---|
